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Abstract  
A simple invention can at times prove extremely useful. This is the case with 
Plumpy‟nut, a variety of ready-to-use therapeutic food (RUTF) conceived in 1999 that 
is shaping a new regime for emergency interventions to alleviate child malnutrition. 
This paper applies concepts from the innovation systems literature into the analysis of 
Plumpy‟nut with the aim of identifying the forces driving its successful diffusion as an 
innovation. Special attention is paid to three features that define the diffusion process: 
1) shifting from inpatient to outpatient treatment, 2) building networks through licences, 
franchises and partnerships, and 3) exploring further varieties of application. We 
combine the theoretical discussion with insights from field research in Ethiopia, 
including personal interviews with relevant parties and direct observation of how 
Plumpy‟nut works in practice. The ultimate objectives of this technology assessment 
exercise are to better understand the innovation journey of Plumpy‟nut and to identify 
possible opportunities for policy intervention. 
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1 Introduction 
 
The United Nations Millennium Development Goals set forth the objective of cutting 
malnutrition in half by 2015. But the Food and Agriculture Organization (FAO) of the 
United Nations estimates that the number of hungry people will reach 1,020 million in 
2009 (or almost one sixth of humanity), which represents an increase of around 200 
million since the 1990 baseline period (FAO 2009). Africa and Asia are the most 
affected regions; and children living in rural areas the most vulnerable. Children under 
the age of five are particularly at risk from malnutrition, among other reasons because 
of their more demanding dietary requirements. According to Médecins Sans Frontières, 
nine children under the age of five die every minute of causes related to malnutrition 
(MSF 2008). Thus most emergency interventions to alleviate the effects of hunger tend 
to focus on children.  
 
Eradicating hunger is one of the most pressing societal challenges of our times, and the 
lack of progress a shameful failure of the international governance system. The paradox 
is that hunger increases despite the fact that there is enough food available for all. 
Reasons explaining this paradox include institutional shortcomings, lack of sufficient 
political will, natural catastrophes and armed conflicts (Sen 1982). In recent times new 
barriers have emerged, including climate change, rise of food prices, increased use of 
bio-fuels and the global economic crisis that started in mid-2007 (Morris et al. 2008; 
Oya 2009; Piessea and Thirtle 2009; Sheeran 2008). Innovation in the fight against 
hunger has become essential to balance out the negative impact of these trends. 
 
The fight against hunger comprises two complementary strategies. The first is to 
provide technical and financial assistance to the least developed countries to help them 
achieve food security, a broad concept that includes critical attributes of food necessary 
for healthy populations such as sufficiency, reliability, quality, safety and timeliness 
(Juma 2007). The attainment of food security requires rural development, political 
stability and peace, infrastructure development and sustained economic growth. The 
second strategy is to deploy emergency interventions to provide food and therapeutic 
components to address malnutrition in the event of a crisis. Even if we accept that the 
best approach is the pursuit of the first strategy, it is also imperative to consider 
emergency solutions, and any kind of inflexibility in the strategy employed to fight 
malnutrition would be grossly unrealistic. Thus, both the governments of the least 
developed countries and the international community should combine both routes of 
action.  
 
In this endeavour, innovation in the fight against hunger may manifest itself through 
different channels. Within the first strategy, the focus is to facilitate the development 
and transfer of agricultural technology and know-how more appropriate for the least 
developed countries, including irrigation techniques, fertilizers and transgenic crops 
(Spielman 2007; Thomas 2005; Naylor et al. 2004). A recent example of success on this 
front is Nerica, a new rice variety developed for Africa in the mid-1990s (Somado et al. 
2008). Within the second strategy, the focus is to develop new types of therapeutic food 
and delivery practices that raise the efficiency of emergency interventions. A recent 
example is Plumpy‟nut, a new variety of RUTF that is driving a new approach for 
emergency interventions to alleviate child malnutrition, as we shall argue in this paper.  
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Plumpy‟nut is the commercial name of a protein-packed, nutrient-dense paste that 
requires neither refrigeration nor preparation. It was developed by a public-private 
partnership of Nutriset, a French private firm specializing in therapeutic food, and the 
Institute of Research for Development, a French public research institute based in Paris. 
The invention was patented and Nutriset‟s factory launched production in 2001. The 
aim of this paper is to analyze how Plumpy‟nut was invented and further employed in 
the fight against hunger throughout the world, drawing attention to the factors that 
explain its diffusion and the features that define the new technological regime.  
 
2 Methodology and sources  
 
The theoretical contribution of this paper consists in applying concepts from the 
innovation systems framework to the analysis of Plumpy‟nut as a new solution to fight 
hunger. Many studies (some of which will be cited throughout the text) have analyzed 
Plumpy‟nut from the perspectives of nutrition science or development assistance; but 
none to the best of our knowledge has done so from an innovation systems perspective.  
 
The empirical contribution is based on field research in Ethiopia. This field research 
was conducted in September 2008, comprising 11 personal interviews with experts and 
direct observation of how Plumpy‟nut works in practice. The interviewees were field 
representatives from international organizations and NGOs, social workers and local 
manufacturers of Plumpy‟nut. Throughout the paper we will provide testimonies from 
some of the interviewees, while the full list is available from the authors upon request.  
 
The triangulation of sources, and the fact that earlier drafts of the paper were circulated 
for comments among some of the interviewees and other experts, both increase the 
validity of our case study research (Yin, 2003). Other sources besides direct observation 
and interviews include: 
- An analysis of policy documents and white papers from international organizations 
and NGOs. 
- Information provided by Nutriset through its website (www.nutriset.fr). 
- An analysis of the patent of Plumpy‟nut in the European and U.S. patent offices. 
- A multidisciplinary literature review. 
 
The rest of the paper is organized as follows. Section 3 introduces a set of concepts and 
theories from the innovation systems literature that bring insight to the study of 
Plumpy‟nut. Section 4 describes the „innovation journey‟ of Plumpy‟nut building on 
those theoretical concepts and the abovementioned sources. Section 5 completes the 
paper with some conclusions and suggestions for the development of policy platforms. 
 
3 Theoretical concepts to analyse Plumpy’nut from an innovation systems 
framework  
 
We describe Plumpy‟nut as an innovation, following its dynamic trajectory from 
invention to experimentation and to full application in multiple contexts. In its most 
broadly accepted definition (OECD 2006, “Oslo Manual”), innovation implies the 
introduction of new products or services into the market (product innovation), the use of 
new production processes (process innovation) or the implementation of new 
organizational or commercial practices (organizational and marketing innovations). As 
opposed to invention, in order to innovate it is not sufficient to discover something new 
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since innovation is associated with the commercialization of a new product/service or to 
the efficient application of a new process. Evolutionary economics and the innovation 
systems framework characterize innovation as an interactive process, where both formal 
and informal interactions between the different agents play a critical role in the 
diffusion process, which in turn is influenced by policies, incremental learning and tacit 
knowledge (Edquist 1997; Freeman 1987; Kline and Rosenberg 1986; Lundvall 1992; 
Nelson and Winter 1982). Thus, the diffusion of innovations occurs within techno-
economic networks; a set of heterogeneous actors (laboratories, technical research 
centres, industrial companies, financial organisations, users, and public authorities) 
which via many interactions organise the relationships between scientific and technical 
research and the marketplace (Callon et al. 1992).  
 
The vast literature on technology diffusion spans different disciplines and focuses on the 
reasons behind the S-curve that characterizes the rate of adoption of a new technology 
over time (see Geroski 2000 for a review). Rogers (1995) defines diffusion as the 
process by which an innovation is communicated through different channels over a 
period of time among the members of a social system, drawing attention to the 
conditions which increase (or decrease) the likelihood that a new idea, product or 
practice will be adopted by members of a given community. This social system is 
inhabited by actors that can be categorized in relation to their readiness to adopt 
innovations and in relation to their influence over other actors in the system. Early 
adopters, opinion leaders and change agents exert a critical role in the process of 
diffusion. Diffusion depends on the perceived characteristics of the innovation, in 
particular its relative advantage vis à vis competing technologies, as well as on its 
compatibility with other technologies and values or beliefs. Flexibility in the process of 
adoption may reduce mistakes and encourage customization of the innovation to fit 
more appropriately into local contexts or changing conditions. On the opposite side, 
many different factors might raise switching costs, such as complexity, lack of 
trialibility or lack of observability of the consequences of the innovation (Rogers 1995; 
Geroski 2000).  
 
A frequent critique to Rogers‟s theory is that the view of adoption as the outcome of a 
communication process among users overemphasizes the demand side of innovation 
and does not pay sufficient attention to the supply side. The argument is that studies on 
diffusion “should go beyond the individualistic perspective which stresses the 
innovativeness of potential adopters, and should examine instead the institutional and 
market structures that channel new technologies to users” (Attewell 1992, p. 3). This is 
a relevant theoretical perspective in the study of Plumpy‟nut, which exhibits a market 
structure where supply is quasi-monopolistic thanks to intellectual property rights while 
demand is an oligopoly dominated by a few NGOs and international organizations. In 
this market, it would be unethical for the supplier to abuse the market power granted by 
its patent because new knowledge that helps reduce malnutrition can be conceptualized 
as a global public good, as it addresses a fundamental human right
1
.  
 
Our analysis also builds upon the concept of innovation journeys developed by Rip and 
Schot (2002) within their study of the co-evolution of science, technology and society. 
                                                 
1
 The right to adequate food is covered in the United Nations Charter, the Universal Declaration of 
Human Rights and subsequent international conventions on human rights derived from these (Eide, 
2002). Archibugi and Bizzarri (2005) define the characteristics of global public goods in their analysis of 
vaccines for communicable diseases. 
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At an early stage of the innovation journey, the new socio-technical option is open-
ended and its applications are still fairly uncertain. Over time, the options become 
articulated and link up with the social environment, which changes itself to adapt to the 
possibilities offered by new options. The embedding of technology in society includes 
mutual adaptation with other products, processes, institutions and actors. The diffusion 
of innovations not only requires improvement and mastery of the technology in a 
narrow mechanical sense, but also shifts in organizational procedures and practices. 
Patterns emerge through linkages, alignments and networks, within a trajectory 
characterized by non-linearity and complexity: “there is no path given in advance, the 
actors create a path by walking (sometimes stumbling along)” (Rip and Schot 2002, p. 
158). That said, according to these authors successful innovation journeys always 
comprise three distinct phases:  Building up a protected space, stepping into the real 
world, and sector-level changes.  
 
The ultimate outcome of innovation journeys may be the advent of a new technological 
regime or technological paradigm, which Dosi (1982) defines as a stabilized model or a 
pattern of solution of technological problems. Technological regime transformations 
involve shifts in underlying technological knowledge but also managerial, 
organizational and social changes. The formation of a new regime means that the 
innovation shapes new actions and interactions of the different actors in a social system, 
by imprinting formal and informal rule-sets (Dosi 1982; Georghiou et al. 1986; Nelson 
and Winter 1982). In turn, technological regime transitions are influenced by 
governance and agency issues, such as regime membership, resource interdependencies, 
actor expectations and the ability to coordinate responses (Smith et al. 2005).  
 
The concept of intermediate or appropriate technology is also important for the study of 
the diffusion of an innovation such as Plumpy‟nut. In “Small is Beautiful” (1973), 
Schumacher calls for intermediate technologies tailored to the needs and capabilities of 
developing countries. This author defined intermediate technologies as those where the 
production methods employed are relatively simple (so that the demands for high skills 
are minimized, not only in the production process itself but also in matters of 
organization, raw material supply, financing, marketing, etc.) and where the production 
process relies mainly on local materials and is aimed mainly for local use. Building on 
Schumacher‟s work, appropriate technology was later suggested as a better term than 
intermediate technology, since the latter was thought to be suggestive of inferior or 
second-rate (Akubue 2000; Jequier and Blanc 1983). Appropriate technology is 
characterized by any or several of the following: 
- Low capital investment per unit of output and per employee. 
- Organizational simplicity. 
- High adaptability to a peculiar social and cultural environment. 
- Use of local natural resources. 
- Low cost of final product. 
- High potential for employment. 
 
As we shall show, judged against these criteria Plumpy‟nut is clearly a more appropriate 
technology for the least developed countries than the previous solutions in place to 
respond to malnutrition crises. And this is precisely the central reason behind its 
successful diffusion as an innovation. 
 
4 The innovation journey of Plumpy’nut 
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Building on Rip and Schot (2002) we distinguish three phases in the innovation journey 
of Plumpy‟nut. The first consists in the gestation of the product and in building up a 
protected space. In the second phase, the invention steps into the real world through 
testing and pilot applications. Finally, in the third phase, the innovation experiences a 
wider diffusion and (possibly) leads to a change of technological regime.  
 
4.1 Gestation  
 
In this first phase of innovation journeys, an actor or group of actors envisage a new 
product or process with the potential to address more efficiently a market or societal 
need. In this endeavour, new combinations of existing knowledge are important, as are 
suggestions from users. The inventor then makes specific promises to sponsors in order 
to mobilise resources to be able to transform the technological opportunity into a 
semblance of functionality, in a process of proof of principle (Rip and Schot 2002, p. 
162). Networking and resource mobilization lead to the emergence of a protected space 
for developing the technological opportunity through R&D. In a subsequent stage, 
research work within a protected space might lead to intellectual property rights. 
 
Before Plumpy‟nut was invented, the standard treatment for severe malnutrition was 
F100, a milk powder fortified with vitamins and minerals developed in the 1980s. F100 
needs to be reconstituted with clean drinking water and consumed almost immediately. 
This has significant drawbacks. It requires potable water, energy to heat it, clean 
utensils and a highly precise mix which, once made, only retains its properties for a few 
hours. If left unrefrigerated, the solution spoils and may absorb bacteria that cause 
infectious diseases. This implies that it generally needs to be administered only through 
inpatient nutrition centers where children need to stay for around one month, usually 
with their mothers. The problem is that hospital capacities are limited and that, in 
addition, a mother leaving home and work inevitably puts her other children at risk. 
Crowded hospitals also multiply the risk of epidemics caused by infectious diseases.  
 
Inpatient treatment will always remain necessary for the most complicated cases of 
malnutrition, but the need for an outpatient approach to acute malnutrition without 
complications was clear. The scientific community started looking for alternatives in the 
1990s. The aim was to develop a ready-to-use food supplement that overcame the 
limitations of F100. In 1997, the French scientist André Briend (then at the Institute of 
Research for Development and now at the World Health Organization, WHO) teamed 
up with Michel Lescanne, the director of Nutriset, a French private company founded in 
1986 specializing in therapeutic foods. They developed and tested ready-to-use food in 
the form of chocolate bars with a similar composition as F100. The problem was that 
they melted easily and tasted worse when vitamins and proteins were added.  
 
But in 1999 Briend envisaged an idea while having breakfast with his children that 
caused a shift in their line of research. He found his inspiration while spreading Nutella 
on his toast, which led him to realize that a paste would work better than a bar
2
. The 
formula was gradually improved in partnership with Nutriset and eventually baptized as 
Plumpy‟nut – a combination of the words “plump” and “peanut”. 
 
                                                 
2
 International Herald Tribune, “In Niger, 'Plumpy‟nut' becomes a life-saver”, By Michael Wines, August 
9, 2005  
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Plumpy‟nut is made of peanuts mixed with a sophisticated vitamin complex that 
provides 500 kilocalories in each packet. Each packet contains one dose and is wrapped 
in aluminium. It can be stored without refrigeration for up to two years without losing 
its properties, and does not spoil even after the package is opened. The low density of 
water makes it a hostile environment for microbes and its fat suspension makes vitamins 
and minerals very stable. Because it does not need cooking or preparation, the labour, 
fuel and water demands on poor households are minimized.  
 
Another of Plumpy‟nut‟s virtues is that it takes the treatment of severe malnutrition out 
of hospitals into homes (Collins et al. 2006). Outpatient treatment allows the mother to 
carry on with her usual tasks and frees hospital resources to take care of patients who 
are more seriously ill. Normally, the mother just has to pick up the packets from a 
health center once a week, make sure that her child eats two a day at home (the child 
will eat it with pleasure) and watch as the child puts on weight. In addition, Plumpy‟nut 
can be produced locally without the need to develop advanced technological skills and 
relying mainly on local materials, which was not that easy with previous therapeutic 
food such as F100. Finally, but also important, the evidence so far is that treatment of 
malnutrition through Plumpy‟nut can be achieved at lower costs per patient than former 
approaches, although cost comparisons are not straight-forward (Collins 2004). 
 
Using Rogers‟s terminology, the success of Plumpy‟nut can be attributed to its 
perceived relative advantage, to its compatibility with other processes and values in 
place, and to its simplicity, trialibility and observability. Moreover, Plumpy‟nut can be 
seen as a more appropriate technology than former solutions since its production is 
more simple and requires lower investments, it is highly adaptable to the specific 
environment of poor countries and it uses peanuts which are often available or easy to 
cultivate in the least developed countries.  
 
Once the product had been further developed, the invention was first registered in the 
French patent office in 2000 (patent number 00/13731) and then in the US Patent and 
Trademark Office also in 2000 (patent number 6,346,284) and in the European Patent 
Office in 2001 (patent number AP/1647). The patents obtained for Plumpy‟nut last until 
2018 and cover not only the product itself but also the production process. Although 
both the Institute of Research for Development (IRD) and Nutriset appear as owners, 
after initial registration IRD granted Nutriset an exclusive exploitation licence for the 
patents and brand name co-owned, subject to certain conditions of appropriate use 
(Source: Nutriset).  
 
4.2 Stepping into the real world  
 
Typical activities in this second phase of the innovation journey include the 
development of a prototype, testing, trouble shooting, implementation, learning about 
usage, and preliminary market testing (Rip and Schot 2002). Initial inventions formed in 
protected laboratory conditions may not necessarily remain relevant in the more 
unpredictable world outside the laboratory (Nightingale 2004), hence the ability to 
adjust ideas to implementation conditions becomes critical for technology diffusion, 
which requires not only improvement and mastery of the technology in a narrow 
mechanical sense, but also shifts in organizational procedures and practices. The 
introduction of the new product or process often takes place with a few lead users. The 
visibility of the product increases, and new potential opportunities appear. 
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In the case of Plumpy‟nut, after further developing the product and setting up the 
manufacturing process, the production started in 2001 at Nutriset‟s factory in Malaunay, 
France. The production process was easy to set up given the existing assets and know-
how of Nutriset. The company was already active in the therapeutic food business and 
had strong connections in the market. It was not too hard to convince some major 
donors of the virtues of Plumpy‟nut. They were eager to participate in this kind of 
innovation and were particularly sensitive to its advantages in terms of easier on the 
ground delivery.  
 
According to Enserink (2008) Mark Manary, a nutrition scientist at Washington 
University in St. Louis, Missouri, was the first to test the product in clinical trials, in 
Malawi in 2002. Subsequently, it was used widely on the ground for the first time 
during the humanitarian crises in Darfur, western Sudan, in 2003. In both cases, the 
introduction of Plumpy‟nut was very successful. 
 
4.3 Wider diffusion  
 
Once an innovation proves its value through testing and pilot applications, the third 
phase of the innovation journey involves wider adoption and diffusion. This requires 
sector transformations and new socio-technical linkages, as suppliers orient themselves 
to the new technology and exploit economies of scale and scope, while users recognize 
further varieties of application (Rip and Schot 2002, p. 165). It may also lead, as 
discussed in Section 3, to the stabilization of a new technological regime. 
 
In the case of Plumpy‟nut, after testing in Malawi and the success of its pilot application 
in Sudan, since 2005 it has gradually become the most widely used therapeutic solution 
to fight child malnutrition across Africa. For example, recent successful experiences 
have been reported in Ethiopia (Eklund and Girma 2008), Kenya (Dibari et al. 2008), 
Malawi (Sadler et al. 2008; Linneman et al. 2007), Niger (Defourny et al. 2007; 
Gaboulaud et al. 2007), Sudan (Enserink 2008) and Sierra Leone (Navarro-Colorado 
and Laquière 2005). The record of achievements demonstrates that Plumpy‟nut is more 
efficient than the previous solutions in place (Briend et al. 2006).  
 
Demand and production have greatly expanded. Nutriset (the biggest producer by far) 
produced more than 15,000 tons in 2008 and UNICEF (the biggest buyer) purchased 
around 8,000 tons in 2008 and expects global production to grow to at least 50,000 tons 
by 2011 (Enserink 2008). This growth estimate suggests that, despite its rapid diffusion 
in recent years, Plumpy‟nut is still in an intermediate phase of its S-curve of diffusion. 
The diffusion process has been supported by some NGOs such as MSF, the Bill Clinton 
Foundation or Valid International, which recognized the virtues of Plumpy‟nut and 
acted as early adopters.  
 
In the rest of this section we elaborate further on three specific dimensions of the 
innovation journey of Plumpy‟nut which have been critical drivers of its successful 
diffusion in the past and which we sustain are keys features of the new technological 
regime that is emerging. First, the change in the therapeutic care regime, from inpatient 
to outpatient. Second, the expansion of the supply network through franchises, licenses 
and partnerships. And third, the development of new varieties of application. We will 
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illustrate the discussion with some examples and testimonies from field research in 
Ethiopia and through information provided by Nutriset. 
 
4.3.1 Shifting from inpatient to outpatient care 
 
Traditional approaches to malnutrition crises rely on inpatient therapeutic feeding 
centers (TFC) as their primary mode of intervention, which provide intensive, high-
quality care for severely malnourished patients. As discussed in Briend et al. (2006) and 
Collins (2004), this approach has several drawbacks: 
- TFCs require substantial infrastructure and experienced staff, are expensive, 
difficult to set up, and heavily dependent on external support. 
- Inpatient care prioritizes quality of care at the expense of quantity of care. 
- They are centralized and in rural environments patients often have to travel long 
distances to reach them, especially in settings where the rural population is very 
geographically dispersed. 
- Large number of patients are put in proximity, increasing risks of cross-infection. 
- Mothers have to stay with their malnourished children for around one month, 
undermining family life, in particular the care of other children. 
- Partly as a result of the previous issues, they are often unpopular with the target 
population, which causes people to present for treatment late, often after major 
complications have occurred.  
 
Yet the advent of Plumpy‟nut has enabled a shift to an outpatient treatment regime, 
which overcomes these drawbacks and provides for a stronger participation of local 
communities in the diagnosis and treatment of malnutrition. Indeed, as we argued in 
Section 4.1, one of the main virtues of Plumpy‟nut is that it enables outpatient treatment 
of malnutrition through a system of community-based therapeutic care (CTC). CTC is 
organized around networks of local workers or volunteers who visit household to detect 
cases of malnutrition using simple protocols, and encourage patients to visit nearby 
outpatient medical centers where Plumpy‟nut is provided and patients are monitored. 
Sensitisation and mobilisation of the population initially focus on key community 
figures (such as political and tribal leaders, traditional healers, religious leaders, 
representatives of women‟s groups, etc.) who are informed about the program and asked 
for help in mobilising the wider population (Collins 2004). As the program evolves, 
resources are put into selecting volunteers from the community, who are supported by 
outreach workers employed by the program and are responsible for following up 
malnourished children at their homes, tracing defaulters and finding new cases. CTC 
programs evolve over time and also adapt to differing contexts.  
 
Admission criteria for TFCs normally followed the Standard Weight-for-Height (WFH) 
protocol recommended by WHO, which requires numeracy and the ability to perform 
height/length measurements, use complex tables and perform arithmetic calculations 
using decimal numbers. These requirements have proved problematic when trying to 
mobilise community members as volunteers. But CTC allows for simpler admission 
criteria, using MUAC (mid upper arm circumference) assessment to screen for cases, 
which does not require the user to be numerate or literate (Briend and Zimick 1986).  
 
While CTC have proved to be highly efficient for patients suffering from severe acute 
malnutrition without complications, it needs to be stressed that TFC are still necessary 
for those suffering from severe acute malnutrition with complications, especially when 
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appetite is poor, since these kinds of patients do not respond well and still require 
inpatient treatment including liquid diets (Briend et al. 2006; Gaboulaud 2007).  
 
 
Box 1. Health extension networks: the case of Ethiopia 
 
Despite strong economic growth in recent years, the WHO estimates that 42% of 
children in Ethiopia are underweight. The causes include primitive farming, years of 
poor political management and an uncontrolled birth rate in one of Africa‟s most highly 
populated countries (over 75 million inhabitants). The average rural family has six or 
seven members who live in a 30 square-meter house and farm less than one hectare 
without machinery. “They call them famine plots", explains Marc Rubin, Unicef‟s head 
of operations and emergencies in Ethiopia. “The households are too large and rely on 
plots that are too small". For a family of six that relies on subsistence farming with 
hardly any profit and without the capacity to store surplus, the loss of a harvest due to 
meteorological or other reasons can prove fatal. The population in Ethiopia is mostly 
rural and geographically dispersed throughout a very large country with poor 
infrastructures, hence the invention of Plumpy‟nut in itself is not sufficient to combat 
malnutrition; it also has to reach the target population.  
Against this background, the Government, advised by Unicef, created an 
outpatient network to ensure that Plumpy‟nut arrives where it is needed. “In Ethiopia 
the first huge demand for this product coincided with the health extension program that 
started in 2004", explains Van Steirteghem, the Unicef representative in the country. 
“At that time we had the product and a mechanism to reach the village level. One is 
useless without the other. Thanks to the convergence of both factors, we are managing 
to respond better to this crisis".  
The cornerstone of the program are its “health extension workers”: some 24,000 
young people, mostly women, from rural areas, who receive training and then visit 
families in their community in order to identify malnourished children and advise their 
families to take part in the program. Bedria Tadele is one of these health extension 
workers. She is 22 years old and started in this job two years ago after a recruitment 
process. She feels lucky with her job and states that “you have to compete for the post". 
She trained in the city for one year and now earns a Government wage and is 
responsible, with two colleagues, for a community of 3,188 people in 708 households, 
the same community in which Bedria grew up. She walks miles every day to visit 
between six and ten households. During her home visits, Bedria talks to the mothers, 
observes the children, measures their arm circumference and looks for signs of illness. 
When she detects malnutrition, she explains the situation to the mother and gives her an 
appointment at the closest medical post. These precarious outpatient centres, which 
require no more equipment than a scale to weigh the children, a board to measure them, 
stocks of Plumpy‟nut and a few medicines, have grown in number to the point that 
almost all inhabitants of the region can walk to the nearest one. Children needing more 
sophisticated treatment on arrival are transferred to a better equipped hospital. This is an 
effective health network that starts in households. 
 
 
The ultimate aim of CTC programs is to hand over control in order to help equip local 
communities to deal with future malnutrition crises without the need for external 
support. This evolution is critical because malnutrition crises are evolving from 
sporadic events to which international donors can respond massively and then leave 
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when the problem is solved, towards cyclical crises which reflect structural problems, 
without a clearly defined start or end (Collins 2004). 
 
In conclusion, throughout the diffusion of Plumpy‟nut, a key success factor present in 
all experiences was the community-based management of its provision (Collins et al. 
2006; Eklund and Girma 2008). In some cases, new networks were created almost from 
scratch whereas in others existing community networks were utilized. In fact, an 
advantage of CTC as a form of intervention to fight malnutrition crises are the synergies 
that can be built with other programs, including general hygiene and HIV prevention 
and treatment. In a way, Plumpy‟nut benefited from a wider trend towards local 
participation in health and development assistance programs, while at the same time it 
helped reinforce this trend.  
 
4.3.2 Building a network of franchises, licences and partnerships 
 
Another driver of Plumpy‟nut‟s diffusion has been the increasing willingness of 
Nutriset to share its knowledge and allow manufacturing in the field through franchises, 
licenses and partnership agreements. Initially, the only source of Plumpy‟nut was 
Nutriset‟s factory in France. But as demand increased, in 2005 the company set up a 
franchising scheme enabling the local production and commercialization of the product 
in developing countries using the Plumpy‟nut brand and protected know-how. The first 
local factory was opened in Malawi and since then the so-called “Plumpy‟nut in the 
field” program has expanded to five countries (Ethiopia, Malawi, Niger, Democratic 
Republic of Congo and Dominican Republic). The franchising system is based on the 
transfer of Nutriset‟s know-how (production, management and distribution) to a local, 
independent producer known as the “Franchisee”. Nutriset aims at ensuring 
homogeneity in quality standards and requires the franchisee to adhere to the following 
principles (Source: Nutriset): 
- Assurance of the quality of the local product. 
- Professional ethics of the local partner in his dealings with the humanitarian world. 
- Awareness and adherence to the good use of locally available product. 
- Producer‟s strong commitment to making the product available. 
 
The general benefits of local manufacturing through this franchise system are wide-
reaching. In addition to the transfer of knowledge and the licence to use the patent and 
registered brand name, franchisees benefit from continuous training; assistance and 
quality control; and access to R&D projects and to technological management or 
nutritional improvements (Source: Nutriset). Local production in the field allows for 
significant cost reductions
3
. It also stimulates the local economy by creating jobs and 
transferring technology, while representing an advance towards achieving self-
sufficiency to address malnutrition crises. Indeed, Plumpy‟nut can be manufactured 
easily using basic technology that is readily available in developing countries (Fellows 
2003). The equipment required –a peanut roaster and grinder, and a mixing and filling 
machine– is relatively inexpensive and easy to use and maintain. The production 
process relies mainly on local materials and is intended for local use. The technology 
exhibits low capital investment per employee; organizational simplicity; high 
                                                 
3
 According to Collins et al. (2006), the production cost in Nutriset‟s French factory was around 
US$3,500 per ton, while local manufacturing allows for a price reduction of US$1,000 per ton, without 
taking into account the savings of transport costs. Similarly, Sandige et al. (2004) report cost savings of 
around 50% thanks to local production. 
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adaptability to the local social environment; high potential for employment; and low 
demands for high skills, not only in the production process itself but also in matters of 
organization and raw material supply. These are the main criteria to define a technology 
as intermediate or appropriate to the specificities of the least developed countries, as 
discussed in Section 3. 
 
 
 
Box 2. Local manufacturing through franchises: the case of Ethiopia 
 
We visited the headquarters of Hilina Enriched Food Processing Center in Legetafo, a 
few kilometres north of Ethiopia‟s capital city. This is one of the African franchisees 
that produce Plumpy‟nut in situ. The director, Belete Beyene, proudly shows us around 
the factory that he built from scratch. Capacity will be doubled soon when the new 
1,500-square-metre plant under construction next door is finished. The plant operates 
around the clock in three eight-hour shifts, employing a total of 104 workers, all young 
Ethiopians, 60% women, who earn around 55 dollars a month (20 dollars above the 
minimum wage). When the plant opened in 2007, 100 tons of Plumpy‟nut were 
produced each month and production has now almost tripled. In 2010, when the new 
plant is at full capacity, production is expected to reach 600 tons per month, around half 
of the French factory‟s current production.  
Belete explains how he embarked on this adventure: "Due to the fast growth in 
demand, Unicef studied the possibility of encouraging the transfer of a part of 
production here, where the product is needed. I had a small factory producing a different 
type of therapeutic food. They contacted me and I said I could do it but I needed money. 
They found a sponsor, the American Amy Robbins, who donated 300,000 dollars to 
Unicef. In Ethiopia we have good peanuts, soya oil and cane sugar. We have 80% of the 
necessary materials. We only need to import powdered milk from India and the mix of 
vitamins and minerals that we buy from Nutriset, which also audits process quality". 
(Source: personal interview) 
They now sell their entire production. The main customer is Unicef, which buys 
50%, and the other 50% is distributed among other NGOs, including MSF (10%) and 
the Bill Clinton Foundation (10%). Belete supports the franchise scheme and the 
existence of a patent because he considers that it guarantees control over the activities. 
"A lot of quality controls are needed", he assures us. "This is not just any industrial 
production process. If you‟re not careful you can kill a child".  
 
 
Following the success of the franchise scheme, more recently Nutriset has also offered 
to grant licences to new producers with the purpose of avoiding the risks of monopoly, 
thus making healthy competition possible, and of helping developing countries build 
their own capacity (Source: Nutriset). This proposal was made during (and possibly 
influenced by) Nutriset‟s meeting in Rome in March 2007 with humanitarian 
stakeholders regarding intellectual property rights. The main principles of the licence 
agreement are phrased by Nutriset in the following terms: 
“Nutriset may grant an intuitu personae, non-exclusive and non-transferable license to 
any public or private company or non-governmental organisation, real and serious, 
with headquarters and main shareholders based in a Developing Country, to 
manufacture and market products using the Patent owned by Nutriset/IRD, in 
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Developing Countries. In this kind of agreement, whose aim is to stimulate new product 
design and application development, the producer: 
- Develops its own brand name and distinctive signs. 
- Uses its own quality system. 
Companies without a license are not authorized to produce or market products using 
Nutriset Patents in any way. Nutriset may consider this as an infringement and may 
choose to sue such companies.”(Source: www.nutriset.fr) 
 
In 2008 Nutriset further embraced an open innovation network by signing a strategic 
partnership agreement with Industrial Revelation Initiative, a U.S.-based NGO active in 
nutrition advocacy and in East Africa. This partnership comprises a joint venture called 
Edesia, established in the U.S. in 2009. Edesia‟s mandate comprises the following 
strategic objectives (Source: Nutriset): 
- To set up and subsequently operate a new Plumpy‟nut production site located in the 
US (Providence, Rhode Island), which expects to start production by the beginning 
of 2010. 
- To create a platform of research and development for new nutrition solutions. 
- To forge a closer cooperation with American initiatives acting in developing 
countries.  
- To enable Industrial Revelation Initiative to be an extra support tool for the 
Plumpy‟nut producers network in the developing world (in terms of training, quality 
control, etc.). 
 
Thus this joint venture goes beyond franchising and licensing by representing a stronger 
integration of the partners, with higher involvement of both in strategic activities and 
risk sharing. Besides being an additional sign of Nutriset‟s open model of innovation, 
integrating a U.S. partner into the scene also holds geo-political relevance. For example, 
one can hypothesise that official development assistance programs are influenced by 
lobbies of national NGOs, which may be locked-in to pre-existing knowledge or may 
want to protect their specific competencies. 
 
4.3.3 Exploring further varieties of application 
 
Post-innovation improvements and adaptation to new niches or “further varieties of 
application” (Rip and Schot 2002, p. 165) can exert a critical role in the diffusion of 
innovations and influence technological trajectories in other disciplines or spheres of 
society. Along these lines, it is worth exploring the new varieties of application which 
have emerged for Plumpy‟nut in recent years. 
 
After the introduction of Plumpy‟nut, Nutriset has expanded its product range 
incorporating new packaging and formulation options for RUTF in response to specific 
market niches, such as Plumpy‟doz and Nutributter. Furthermore, both within and 
outside Nutriset, there is a growing interest in the development of new formulae of 
RUTF with different kinds of locally-available grains and legumes, without the addition 
of milk powder or peanuts
4
. Addition of adapted mineral and vitamin supplement to the 
local diet seems also to increase the efficacy of programs based on the use of locally 
available nutrient rich foods, but according to Briend et al. (2006) this approach requires 
further research to determine its effectiveness. 
                                                 
4
 For example, Henry and Seyoum (2004) report on the development of new recipes by Valid 
International in conjunction with Oxford Brookes University. 
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Other varieties of application include treatment of malnutrition in adults and the use of 
Plumpy‟nut not only for alleviation but also for prevention purposes. In the first case, 
Dibari et al. (2008) report experiences in Kenya with malnourished HIV+ adults but call 
for a different approach in the use of Plumpy‟nut since they find a high proportion of 
the patients could not comply with the full prescription due to “dietary boredom” and 
clinical conditions associated with HIV such as lack of appetite and nausea. With regard 
to the use of Plumpy‟nut for prevention purposes, MSF has experimented with mass 
distribution of the product in Niger and is advocating the wider extension of this 
practice. However, as discussed in Enserink (2008), nutrition experts are divided on 
whether this is an efficient approach for prevention. 
 
5 Conclusions and policy implications 
 
The diffusion of Plumpy‟nut is shaping a new technological regime in the deployment 
of emergency interventions to alleviate the effects of malnutrition. The combination of 
RUTF and its feasible provision through outpatient networks is gradually transforming 
the way severe malnutrition is managed. Indeed, the introduction of Plumpy‟nut has 
been accompanied by a shift towards a new treatment regime, with new clinical 
protocols, new professional interactions and, in general, a change in the organisational 
structures that control service delivery. In this sense, the case of Plumpy‟nut is a clear 
example of how the diffusion of a new technology often requires modifications in 
organizational practices and procedures. It is also an example of the difficulty of making 
the difference in practice between product, service, process, organizational and 
marketing innovations, despite the clear taxonomy defined in the OECD Oslo Manual.  
 
International organizations can play a critical role in promoting the application of 
science, technology and innovation in the fight against hunger. A recent example is the 
International Assessment of Agricultural Science and Technology for Development, an 
international panel which after a 4-year process involving over 400 international experts 
issued a statement in 2008 officially calling for a shift of agricultural science and 
technology towards more holistic approaches (www.agassessment.org). This panel has 
already been compared to the Intergovernmental Panel on Climate Change for the 
quality of its governance and the relevance of its recommendations (Vanloqueren and 
Baret 2009). 
 
In the case of RUTF, four international organizations within the United Nations system 
issued a joint statement in 2007 advocating home treatment with RUTF for severely 
malnourished children
5
. By acting as opinion leaders and change agents, they contribute 
to the formation of the emerging technological regime.  
 
Public policies may influence technological regimes in many different ways, including 
research funding orientations, public-private partnerships, and intellectual property 
regulations. As explained by Kuhlmann (2009), research policy for sustainable 
development requires a balanced portfolio of exploratory and problem-oriented 
research, underpinned by substantial socio-economic understanding. This author 
advocates the institutionalization of policy platforms as spaces for interaction and 
                                                 
5
 “Community-Based Management of Severe Acute Malnutrition. A Joint Statement by the World Health 
Organization, the World Food Programme, the United Nations System Standing Committee on Nutrition 
and the United Nations Children's Fund”, May 2007, Geneva. 
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deliberation among key stakeholders from different levels and policy domains, with the 
aim of defining joint policies related to sustainable development.  
 
Along those lines, it would be advisable to further institutionalize a technology 
assessment committee to perform targeted foresight of innovations to fight hunger 
(including ethical, legal and social aspects) and, in particular, of Plumpy‟nut and other 
types of RUTF, bringing together international organizations, NGOs, local 
governments, industry representatives (including Nutriset) and other civil society 
stakeholders. The policy approach should strive for a balance between the public 
funding of basic research (for example to develop new formulae for RUTF using 
different crops) and the support of implementation institutions and guidelines (for 
example through the development of protocols and training programs for efficient 
community-based therapeutic care). The foresight and advisory processes should be 
accountable to the public and aim at gauging the opinion of the countries that suffer 
most from malnutrition. 
 
The patent of Plumpy‟nut is a particular issue worth the attention of such policy 
platforms. Despite the emergence of franchise and licence arrangements described in 
Section 4.3.2, the debate around the patent is still controversial (Enserink 2008). Some 
argue there should be no patents on key humanitarian nutrition products and that, 
indeed, most past inventions in humanitarian nutrition such as F100 or oral rehydration 
therapy were not patented. For others, the patent has helped in quality assurance and has 
so far provided a rational and well organized process of technology transfer. Moreover, 
the private sector is an increasingly important actor in R&D which tends to focus on 
innovations that can be protected by patents, so limiting intellectual property protection 
for innovations such as Plumpy‟nut could have the adverse effect of reducing incentives 
for private firms to engage in much needed R&D. Beyond encouraging Nutriset to 
expand its network of franchises, licences and partnerships, a more aggressive policy 
response could be to include new provisions in international intellectual property 
agreements that promote knowledge-sharing with developing countries. Another role of 
policy makers is to prepare the transition for 2018, when the patent rights of Nutriset 
expire. 
 
Based on our study, policy platforms should also encourage R&D efforts aimed at the 
development of new formulae of RUTF using different kinds of grains and legumes 
other than peanuts, and without the need to add milk-powder, as discussed in Section 
4.3.3. This would accelerate the international diffusion process and enable a higher 
degree of self sufficiency for affected countries. This is an example of how a new 
technological regime shapes further technological trajectories (Dosi 1982). Again, the 
policy approach should include not only targeted R&D funding but also the 
development of spaces for knowledge-sharing and coordination of research initiatives.  
 
Finally, our analysis of Plumpy‟nut may offer some lessons for other innovations in the 
fight against hunger and for other domains such as the treatment of aids or the 
development and provision of vaccines for communicable diseases. These kinds of 
synergies and interdisciplinary learning opportunities should be further explored in 
forthcoming international fora and technology assessment groups. 
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ANNEX 1. Photos from Ethiopia 
 
 
 
A malnourished child taking Plumpy‟nut. 
 
 
 
Bedria Talede, a health extension worker who visits families to diagnose cases of 
malnutrition and prescribe Plumpy‟nut based treatment. 
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A medical post where Plumpy‟nut is distributed and malnourished children are 
monitored using simple protocols. 
 
 
 
 
 
Local manufacturing of Plumpy‟nut at Hilina Enriched Food Processing Center. 
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